The same series of 10 CLL cases was also employed to perform a comparison between the approach by western blot/qRT-PCR and an alternative approach by FACS evaluating the modulation of TP53 and CDKN1A protein expression [26,33,34]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.